Jamieson Wellness, Inc. (JWEL.TO)
45.68
+0.05
(+0.11%)
CAD |
TSX |
Aug 25, 16:00
Jamieson Wellness Enterprise Value : 2.395B for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 2.395B |
| August 24, 2026 | 2.393B |
| August 21, 2026 | 2.395B |
| August 20, 2026 | 2.395B |
| August 19, 2026 | 2.397B |
| August 18, 2026 | 2.392B |
| August 17, 2026 | 2.392B |
| August 14, 2026 | 2.392B |
| August 13, 2026 | 2.394B |
| August 12, 2026 | 2.390B |
| August 11, 2026 | 2.398B |
| August 10, 2026 | 2.392B |
| August 07, 2026 | 2.387B |
| August 06, 2026 | 2.222B |
| August 05, 2026 | 2.222B |
| August 04, 2026 | 2.224B |
| July 31, 2026 | 2.215B |
| July 30, 2026 | 2.212B |
| July 29, 2026 | 2.244B |
| July 28, 2026 | 2.273B |
| July 27, 2026 | 2.258B |
| July 24, 2026 | 2.195B |
| July 23, 2026 | 2.205B |
| July 21, 2026 | 2.221B |
| July 20, 2026 | 2.223B |
| Date | Value |
|---|---|
| July 17, 2026 | 2.244B |
| July 16, 2026 | 2.238B |
| July 15, 2026 | 2.239B |
| July 14, 2026 | 2.231B |
| July 13, 2026 | 2.235B |
| July 10, 2026 | 2.232B |
| July 09, 2026 | 2.208B |
| July 08, 2026 | 2.193B |
| July 07, 2026 | 2.209B |
| July 06, 2026 | 2.234B |
| July 03, 2026 | 2.241B |
| July 02, 2026 | 2.234B |
| June 30, 2026 | 2.229B |
| June 29, 2026 | 2.223B |
| June 26, 2026 | 2.183B |
| June 25, 2026 | 2.148B |
| June 24, 2026 | 1.991B |
| June 23, 2026 | 1.987B |
| June 22, 2026 | 1.985B |
| June 19, 2026 | 1.995B |
| June 18, 2026 | 2.007B |
| June 17, 2026 | 2.037B |
| June 16, 2026 | 2.011B |
| June 15, 2026 | 1.998B |
| June 12, 2026 | 1.981B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Leef Brands, Inc. | 100.82M |
| NeutriSci International, Inc. | -- |
| Vitality Products, Inc. | 1.460M |
| Genix Pharmaceuticals Corp. | 1.983M |
| LSL Pharma Group, Inc. | 85.38M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 18.61M |
| Revenue (Quarterly) | 233.84M |
| Total Expenses (Quarterly) | 215.90M |
| EPS Diluted (Quarterly) | 0.4172 |
| Gross Profit Margin (Quarterly) | 41.65% |
| Profit Margin (Quarterly) | 7.96% |
| Earnings Yield | 4.01% |
| Operating Earnings Yield | 6.67% |
| Normalized Earnings Yield | 3.872 |